Every day, Maimonides Cancer Center brings patients leading-edge treatments, right here in Brooklyn.
While participating in a clinical trial is not for everyone, there may be potential benefits, such as providing an alternative method of care, and you may help researchers answer important questions about promising new treatments, which could lead to advances in the way cancer is treated in the future.
Choosing to participate in a clinical trial is an important personal decision. Our goal is to provide information to help you decide whether or not to take part in a cancer research trial. Patients must meet certain requirements to participate in clinical trials.
For information about participating in a cancer clinical trial, please contact:
Public reporting of outcomes in 2016
Maimonides compares our performance rates in the National Quality Forum (NQF) standards for care to the performance rates of other hospitals in New York State and the American College of Surgeons Eastern Division to ensure we are providing quality care.
Data as of 2016
The national standard for removal and examination of lymph nodes in colon cancer
Facts about cancer clinical trials
- More than 25,000 cancer patients enroll each year in clinical trials through the National Cancer Institute. Many more patients are enrolled in clinical trials sponsored by other groups
- About 60% of the adults enrolled in clinical trials are women
- Lung, breast, prostate, and colon cancers have the highest number of clinical trials — more than 40% of the total number of trials
- Only a small percentage of all cancer patients enroll in clinical trials. Their participation may benefit them as well as future cancer patients
For more information about clinical trials in your area or general information about cancer research, refer to: